Betterment’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Betterment's XBI Position: Q2 2026 in Review
Betterment increased its State Street SPDR S&P Biotech ETF (XBI) stake by 31% in Q2 2026, buying an estimated $130K and bringing the position to 4,112 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #428.
Betterment first reported a position in XBI in Q4 2025 and has held it in 3 quarters since. 939 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Betterment held 4,112 shares of State Street SPDR S&P Biotech ETF worth $651K as of Q2 2026.
- Betterment bought 964 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $130K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Betterment's portfolio in Q2 2026, its #428 holding.
- Betterment first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 3 quarters since.
- 939 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Betterment's 13F filing for Q2 2026, filed 14 Aug 2026.